Interim analysis of data from a long-term, extension trial of tafamidis meglumine in patients with transthyretin amyloid cardiomyopathy
31 August 2019 (00:00 - 00:00)
Organised by:
About the speaker
University of Maryland, Baltimore (United States of America)
8 More presentations in this session
Doctor V. Algalarrondo (Paris, FR)
Doctor T. Kotecha (London, GB)
Professor A. Caforio (Padova, IT)
Access the full session
The Event
ESC Congress 2019
31 August - 4 September 2019
